Assessment of Urine Proteomics in Type 1 Primary Hyperoxaluria

Ellen R. Brooks, Bernd Hoppe, Dawn S. Milliner, Eduardo Salido, John Rim, Leah M. Krevitt, Julie B. Olson, Heather E. Price, Gulsah Vural, Craig B. Langman

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

Background: Primary hyperoxaluria type 1 (PH1) and idiopathic hypercalciuria (IHC) are stone-forming diseases that may result in the formation of calcium (Ca) oxalate (Ox) stones, nephrocalcinosis, and progressive chronic kidney disease (CKD). Poorer clinical outcome in PH1 is segregated by the highest urine (Ur)-Ox (UrOx), while IHC outcomes are not predictable by UrCa. We hypothesized that differences would be found in selected Ur-protein (PRO) patterns in PH1 and IHC, compared to healthy intra-familial sibling controls (C) of PH1 patients. We also hypothesized that the PRO patterns associated with higher UrOx levels would reflect injury, inflammation, biomineralization, and abnormal tissue repair processes in PH1. Methods: Twenty four-hour Ur samples were obtained from 3 cohorts: PH1 (n = 47); IHC (n = 35) and C (n = 13) and were analyzed using targeted platform-based multi-analyte profile immunoassays and for UrOx and UrCa by biochemical measurements. Results: Known stone matrix constituents, osteopontin, calbindin, and vitronectin were lowest in PH1 (C > IHC > PH1; p <0.05). Ur-interleukin-10; chromogranin A; epidermal growth factor (EGF); insulin-like growth factor-1 (IGF-1), and macrophage inflammatory PRO-1α (MIP-1α) were higher in PH1 > C (p = 0.03 to p <0.05). Fetuin A; IGF-1, MIP-1α, and vascular cell adhesion molecule-1 were highest in PH1 > IHC (p <0.001 to p = 0.005). Conclusion: PH1 Ur-PROs reflected overt inflammation, chemotaxis, oxidative stress, growth factors (including EGF), and pro-angiogenic and calcification regulation/inhibition compared to the C and IHC cohorts. Many of the up- and downregulated PH1-PROs found in this study are also found in CKD, acute kidney injury, stone formers, and/or stone matrices. Further data analyses may provide evidence for PH1 unique PROs or demonstrate a poorer clinical outcome.

Original languageEnglish (US)
Pages (from-to)293-303
Number of pages11
JournalAmerican Journal of Nephrology
DOIs
StateAccepted/In press - May 3 2016

Fingerprint

Proteomics
Hypercalciuria
Urine
Chronic Renal Insufficiency
Primary hyperoxaluria type 1
Nephrocalcinosis
Inflammation
Vitronectin
Calbindins
Calcium Oxalate
Osteopontin
Kidney Calculi
Oxalates
Chemotaxis
Immunoassay
Acute Kidney Injury
Siblings
Intercellular Signaling Peptides and Proteins
Proteins
Oxidative Stress

Keywords

  • Calcium oxalate crystals
  • Epidermal growth factor
  • Fetuin A
  • Idiopathic hypercalciuria
  • Osteopontin
  • Primary hyperoxaluria type 1
  • Tam Horsfall protein
  • Urine oxalate
  • Urine proteomics

ASJC Scopus subject areas

  • Nephrology

Cite this

Brooks, E. R., Hoppe, B., Milliner, D. S., Salido, E., Rim, J., Krevitt, L. M., ... Langman, C. B. (Accepted/In press). Assessment of Urine Proteomics in Type 1 Primary Hyperoxaluria. American Journal of Nephrology, 293-303. https://doi.org/10.1159/000445448

Assessment of Urine Proteomics in Type 1 Primary Hyperoxaluria. / Brooks, Ellen R.; Hoppe, Bernd; Milliner, Dawn S.; Salido, Eduardo; Rim, John; Krevitt, Leah M.; Olson, Julie B.; Price, Heather E.; Vural, Gulsah; Langman, Craig B.

In: American Journal of Nephrology, 03.05.2016, p. 293-303.

Research output: Contribution to journalArticle

Brooks, ER, Hoppe, B, Milliner, DS, Salido, E, Rim, J, Krevitt, LM, Olson, JB, Price, HE, Vural, G & Langman, CB 2016, 'Assessment of Urine Proteomics in Type 1 Primary Hyperoxaluria', American Journal of Nephrology, pp. 293-303. https://doi.org/10.1159/000445448
Brooks ER, Hoppe B, Milliner DS, Salido E, Rim J, Krevitt LM et al. Assessment of Urine Proteomics in Type 1 Primary Hyperoxaluria. American Journal of Nephrology. 2016 May 3;293-303. https://doi.org/10.1159/000445448
Brooks, Ellen R. ; Hoppe, Bernd ; Milliner, Dawn S. ; Salido, Eduardo ; Rim, John ; Krevitt, Leah M. ; Olson, Julie B. ; Price, Heather E. ; Vural, Gulsah ; Langman, Craig B. / Assessment of Urine Proteomics in Type 1 Primary Hyperoxaluria. In: American Journal of Nephrology. 2016 ; pp. 293-303.
@article{425a2a3f9956405ebe5d6fcc75489024,
title = "Assessment of Urine Proteomics in Type 1 Primary Hyperoxaluria",
abstract = "Background: Primary hyperoxaluria type 1 (PH1) and idiopathic hypercalciuria (IHC) are stone-forming diseases that may result in the formation of calcium (Ca) oxalate (Ox) stones, nephrocalcinosis, and progressive chronic kidney disease (CKD). Poorer clinical outcome in PH1 is segregated by the highest urine (Ur)-Ox (UrOx), while IHC outcomes are not predictable by UrCa. We hypothesized that differences would be found in selected Ur-protein (PRO) patterns in PH1 and IHC, compared to healthy intra-familial sibling controls (C) of PH1 patients. We also hypothesized that the PRO patterns associated with higher UrOx levels would reflect injury, inflammation, biomineralization, and abnormal tissue repair processes in PH1. Methods: Twenty four-hour Ur samples were obtained from 3 cohorts: PH1 (n = 47); IHC (n = 35) and C (n = 13) and were analyzed using targeted platform-based multi-analyte profile immunoassays and for UrOx and UrCa by biochemical measurements. Results: Known stone matrix constituents, osteopontin, calbindin, and vitronectin were lowest in PH1 (C > IHC > PH1; p <0.05). Ur-interleukin-10; chromogranin A; epidermal growth factor (EGF); insulin-like growth factor-1 (IGF-1), and macrophage inflammatory PRO-1α (MIP-1α) were higher in PH1 > C (p = 0.03 to p <0.05). Fetuin A; IGF-1, MIP-1α, and vascular cell adhesion molecule-1 were highest in PH1 > IHC (p <0.001 to p = 0.005). Conclusion: PH1 Ur-PROs reflected overt inflammation, chemotaxis, oxidative stress, growth factors (including EGF), and pro-angiogenic and calcification regulation/inhibition compared to the C and IHC cohorts. Many of the up- and downregulated PH1-PROs found in this study are also found in CKD, acute kidney injury, stone formers, and/or stone matrices. Further data analyses may provide evidence for PH1 unique PROs or demonstrate a poorer clinical outcome.",
keywords = "Calcium oxalate crystals, Epidermal growth factor, Fetuin A, Idiopathic hypercalciuria, Osteopontin, Primary hyperoxaluria type 1, Tam Horsfall protein, Urine oxalate, Urine proteomics",
author = "Brooks, {Ellen R.} and Bernd Hoppe and Milliner, {Dawn S.} and Eduardo Salido and John Rim and Krevitt, {Leah M.} and Olson, {Julie B.} and Price, {Heather E.} and Gulsah Vural and Langman, {Craig B.}",
year = "2016",
month = "5",
day = "3",
doi = "10.1159/000445448",
language = "English (US)",
pages = "293--303",
journal = "American Journal of Nephrology",
issn = "0250-8095",
publisher = "S. Karger AG",

}

TY - JOUR

T1 - Assessment of Urine Proteomics in Type 1 Primary Hyperoxaluria

AU - Brooks, Ellen R.

AU - Hoppe, Bernd

AU - Milliner, Dawn S.

AU - Salido, Eduardo

AU - Rim, John

AU - Krevitt, Leah M.

AU - Olson, Julie B.

AU - Price, Heather E.

AU - Vural, Gulsah

AU - Langman, Craig B.

PY - 2016/5/3

Y1 - 2016/5/3

N2 - Background: Primary hyperoxaluria type 1 (PH1) and idiopathic hypercalciuria (IHC) are stone-forming diseases that may result in the formation of calcium (Ca) oxalate (Ox) stones, nephrocalcinosis, and progressive chronic kidney disease (CKD). Poorer clinical outcome in PH1 is segregated by the highest urine (Ur)-Ox (UrOx), while IHC outcomes are not predictable by UrCa. We hypothesized that differences would be found in selected Ur-protein (PRO) patterns in PH1 and IHC, compared to healthy intra-familial sibling controls (C) of PH1 patients. We also hypothesized that the PRO patterns associated with higher UrOx levels would reflect injury, inflammation, biomineralization, and abnormal tissue repair processes in PH1. Methods: Twenty four-hour Ur samples were obtained from 3 cohorts: PH1 (n = 47); IHC (n = 35) and C (n = 13) and were analyzed using targeted platform-based multi-analyte profile immunoassays and for UrOx and UrCa by biochemical measurements. Results: Known stone matrix constituents, osteopontin, calbindin, and vitronectin were lowest in PH1 (C > IHC > PH1; p <0.05). Ur-interleukin-10; chromogranin A; epidermal growth factor (EGF); insulin-like growth factor-1 (IGF-1), and macrophage inflammatory PRO-1α (MIP-1α) were higher in PH1 > C (p = 0.03 to p <0.05). Fetuin A; IGF-1, MIP-1α, and vascular cell adhesion molecule-1 were highest in PH1 > IHC (p <0.001 to p = 0.005). Conclusion: PH1 Ur-PROs reflected overt inflammation, chemotaxis, oxidative stress, growth factors (including EGF), and pro-angiogenic and calcification regulation/inhibition compared to the C and IHC cohorts. Many of the up- and downregulated PH1-PROs found in this study are also found in CKD, acute kidney injury, stone formers, and/or stone matrices. Further data analyses may provide evidence for PH1 unique PROs or demonstrate a poorer clinical outcome.

AB - Background: Primary hyperoxaluria type 1 (PH1) and idiopathic hypercalciuria (IHC) are stone-forming diseases that may result in the formation of calcium (Ca) oxalate (Ox) stones, nephrocalcinosis, and progressive chronic kidney disease (CKD). Poorer clinical outcome in PH1 is segregated by the highest urine (Ur)-Ox (UrOx), while IHC outcomes are not predictable by UrCa. We hypothesized that differences would be found in selected Ur-protein (PRO) patterns in PH1 and IHC, compared to healthy intra-familial sibling controls (C) of PH1 patients. We also hypothesized that the PRO patterns associated with higher UrOx levels would reflect injury, inflammation, biomineralization, and abnormal tissue repair processes in PH1. Methods: Twenty four-hour Ur samples were obtained from 3 cohorts: PH1 (n = 47); IHC (n = 35) and C (n = 13) and were analyzed using targeted platform-based multi-analyte profile immunoassays and for UrOx and UrCa by biochemical measurements. Results: Known stone matrix constituents, osteopontin, calbindin, and vitronectin were lowest in PH1 (C > IHC > PH1; p <0.05). Ur-interleukin-10; chromogranin A; epidermal growth factor (EGF); insulin-like growth factor-1 (IGF-1), and macrophage inflammatory PRO-1α (MIP-1α) were higher in PH1 > C (p = 0.03 to p <0.05). Fetuin A; IGF-1, MIP-1α, and vascular cell adhesion molecule-1 were highest in PH1 > IHC (p <0.001 to p = 0.005). Conclusion: PH1 Ur-PROs reflected overt inflammation, chemotaxis, oxidative stress, growth factors (including EGF), and pro-angiogenic and calcification regulation/inhibition compared to the C and IHC cohorts. Many of the up- and downregulated PH1-PROs found in this study are also found in CKD, acute kidney injury, stone formers, and/or stone matrices. Further data analyses may provide evidence for PH1 unique PROs or demonstrate a poorer clinical outcome.

KW - Calcium oxalate crystals

KW - Epidermal growth factor

KW - Fetuin A

KW - Idiopathic hypercalciuria

KW - Osteopontin

KW - Primary hyperoxaluria type 1

KW - Tam Horsfall protein

KW - Urine oxalate

KW - Urine proteomics

UR - http://www.scopus.com/inward/record.url?scp=84966391977&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84966391977&partnerID=8YFLogxK

U2 - 10.1159/000445448

DO - 10.1159/000445448

M3 - Article

C2 - 27161247

AN - SCOPUS:84966391977

SP - 293

EP - 303

JO - American Journal of Nephrology

JF - American Journal of Nephrology

SN - 0250-8095

ER -